I. Vorotnikov

Bone marrow B-lymphocyte subpopulations of breast cancer patients in the prognosis of the disease

N. Tupitsyn, F. K. Berdova, I. Vorotnikov, 2022, Russian Journal of Biotherapy.

Breast cancer: analysis of driver somatic mutations detected by next-generation sequencing

S. A. Zarubina, D. Korostin, V. V. Il’inskii, 2017 .

OF BRCA 1 / 2 MUTATIONS IN BREAST CANCER PATIENTS BY NEXT-GENERATION

I. Vorotnikov, Оксана Сергеевна Дружиловская, A. Churov, 2019 .

Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels

M. Suntsova, N. Gaifullin, A. Buzdin, 2020, Biochemistry (Moscow).

Soluble forms of PD-1/PD-L immune checkpoint receptor and ligand in blood serum of breast cancer patients: association with clinical pathologic factors and molecular type of the tumor.

N. Kushlinskii, E. Korotkova, V. Ermilova, 2022, Russian Clinical Laboratory Diagnostics.